Associations between body mass index and the risk of renal events in patients with type 2 diabetes

<p>Background/Objectives: We aimed to evaluate the relationship between BMI and the risk of renal disease in patients with type 2 diabetes in the Action in Diabetes and Vascular Disease: PreterAx and DiamicroN Modified-Release Controlled Evaluation (ADVANCE) study.</p><p> Subjects/...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Mohammedi, K, Chalmers, J, Herrington, W, Li, Q, Mancia, G, Marre, M, Poulter, N, Rodgers, A, Williams, B, Perkovic, V, Coresh, J, Woodward, M
التنسيق: Journal article
منشور في: Nature Publishing Group 2018
_version_ 1826292491941314560
author Mohammedi, K
Chalmers, J
Herrington, W
Li, Q
Mancia, G
Marre, M
Poulter, N
Rodgers, A
Williams, B
Perkovic, V
Coresh, J
Woodward, M
author_facet Mohammedi, K
Chalmers, J
Herrington, W
Li, Q
Mancia, G
Marre, M
Poulter, N
Rodgers, A
Williams, B
Perkovic, V
Coresh, J
Woodward, M
author_sort Mohammedi, K
collection OXFORD
description <p>Background/Objectives: We aimed to evaluate the relationship between BMI and the risk of renal disease in patients with type 2 diabetes in the Action in Diabetes and Vascular Disease: PreterAx and DiamicroN Modified-Release Controlled Evaluation (ADVANCE) study.</p><p> Subjects/Methods: Participants were divided into 6 baseline BMI categories: &lt;18.5 (underweight, n=58); ≥18.5 – &lt;25 (normal, n=2894); ≥25 – &lt;30 (overweight, n=4340); ≥30 – &lt;35 (obesity grade 1, n=2265); ≥35 – &lt;40 (obesity grade 2, n=744); and ≥40 kg/m2 (obesity grade 3, n=294); those underweight were excluded. The composite outcome “major renal event” was defined as development of new macroalbuminuria, doubling of creatinine, end stage renal disease, or renal death. These outcomes and development of new microalbuminuria were considered individually as secondary endpoints.</p><p> Results: During 5-years of follow-up, major renal events occurred in 487 (4.6%) patients. The risk increased with higher BMI. Multivariable-adjusted HRs (95%CIs), compared to normal weight, were: 0.91 (0.72 – 1.15) for overweight; 1.03 (0.77 – 1.37) for obesity grade 1; 1.42 (0.98 – 2.07) for grade 2; and 2.16 (1.34 – 3.48) for grade 3 (p for trend=0.006). These findings were similar across subgroups by randomized interventions (intensive versus standard glucose control and perindopril-indapamide versus placebo). Every additional unit of BMI over 25 kg/m2 increased the risk of major renal events by 4 (1 – 6)%. Comparable results were observed with the risk of secondary endpoints.</p><p> Conclusions: Higher BMI is an independent predictor of major renal events in patients with type 2 diabetes. Our findings encourage weight loss to improve nephroprotection in these patients. </p>
first_indexed 2024-03-07T03:15:32Z
format Journal article
id oxford-uuid:b5a47d41-2bd4-4dd9-ad1d-21c7af1b122f
institution University of Oxford
last_indexed 2024-03-07T03:15:32Z
publishDate 2018
publisher Nature Publishing Group
record_format dspace
spelling oxford-uuid:b5a47d41-2bd4-4dd9-ad1d-21c7af1b122f2022-03-27T04:35:15ZAssociations between body mass index and the risk of renal events in patients with type 2 diabetesJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:b5a47d41-2bd4-4dd9-ad1d-21c7af1b122fSymplectic Elements at OxfordNature Publishing Group2018Mohammedi, KChalmers, JHerrington, WLi, QMancia, GMarre, MPoulter, NRodgers, AWilliams, BPerkovic, VCoresh, JWoodward, M<p>Background/Objectives: We aimed to evaluate the relationship between BMI and the risk of renal disease in patients with type 2 diabetes in the Action in Diabetes and Vascular Disease: PreterAx and DiamicroN Modified-Release Controlled Evaluation (ADVANCE) study.</p><p> Subjects/Methods: Participants were divided into 6 baseline BMI categories: &lt;18.5 (underweight, n=58); ≥18.5 – &lt;25 (normal, n=2894); ≥25 – &lt;30 (overweight, n=4340); ≥30 – &lt;35 (obesity grade 1, n=2265); ≥35 – &lt;40 (obesity grade 2, n=744); and ≥40 kg/m2 (obesity grade 3, n=294); those underweight were excluded. The composite outcome “major renal event” was defined as development of new macroalbuminuria, doubling of creatinine, end stage renal disease, or renal death. These outcomes and development of new microalbuminuria were considered individually as secondary endpoints.</p><p> Results: During 5-years of follow-up, major renal events occurred in 487 (4.6%) patients. The risk increased with higher BMI. Multivariable-adjusted HRs (95%CIs), compared to normal weight, were: 0.91 (0.72 – 1.15) for overweight; 1.03 (0.77 – 1.37) for obesity grade 1; 1.42 (0.98 – 2.07) for grade 2; and 2.16 (1.34 – 3.48) for grade 3 (p for trend=0.006). These findings were similar across subgroups by randomized interventions (intensive versus standard glucose control and perindopril-indapamide versus placebo). Every additional unit of BMI over 25 kg/m2 increased the risk of major renal events by 4 (1 – 6)%. Comparable results were observed with the risk of secondary endpoints.</p><p> Conclusions: Higher BMI is an independent predictor of major renal events in patients with type 2 diabetes. Our findings encourage weight loss to improve nephroprotection in these patients. </p>
spellingShingle Mohammedi, K
Chalmers, J
Herrington, W
Li, Q
Mancia, G
Marre, M
Poulter, N
Rodgers, A
Williams, B
Perkovic, V
Coresh, J
Woodward, M
Associations between body mass index and the risk of renal events in patients with type 2 diabetes
title Associations between body mass index and the risk of renal events in patients with type 2 diabetes
title_full Associations between body mass index and the risk of renal events in patients with type 2 diabetes
title_fullStr Associations between body mass index and the risk of renal events in patients with type 2 diabetes
title_full_unstemmed Associations between body mass index and the risk of renal events in patients with type 2 diabetes
title_short Associations between body mass index and the risk of renal events in patients with type 2 diabetes
title_sort associations between body mass index and the risk of renal events in patients with type 2 diabetes
work_keys_str_mv AT mohammedik associationsbetweenbodymassindexandtheriskofrenaleventsinpatientswithtype2diabetes
AT chalmersj associationsbetweenbodymassindexandtheriskofrenaleventsinpatientswithtype2diabetes
AT herringtonw associationsbetweenbodymassindexandtheriskofrenaleventsinpatientswithtype2diabetes
AT liq associationsbetweenbodymassindexandtheriskofrenaleventsinpatientswithtype2diabetes
AT manciag associationsbetweenbodymassindexandtheriskofrenaleventsinpatientswithtype2diabetes
AT marrem associationsbetweenbodymassindexandtheriskofrenaleventsinpatientswithtype2diabetes
AT poultern associationsbetweenbodymassindexandtheriskofrenaleventsinpatientswithtype2diabetes
AT rodgersa associationsbetweenbodymassindexandtheriskofrenaleventsinpatientswithtype2diabetes
AT williamsb associationsbetweenbodymassindexandtheriskofrenaleventsinpatientswithtype2diabetes
AT perkovicv associationsbetweenbodymassindexandtheriskofrenaleventsinpatientswithtype2diabetes
AT coreshj associationsbetweenbodymassindexandtheriskofrenaleventsinpatientswithtype2diabetes
AT woodwardm associationsbetweenbodymassindexandtheriskofrenaleventsinpatientswithtype2diabetes